Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The primary objective of this study is to compare gravity-driven versus wall suction-driven large volume therapeutic thoracentesis on the development of chest discomfort during the procedure.
This study is a multicenter, single-blinded, randomized controlled trial designed to compare chest discomfort between gravity-driven and wall suction-driven therapeutic thoracentesis. Patients will be stratified by study centers, and randomly assigned to intervention and control arms; and will remain blinding to their group assignment during the procedure.
Full description
Aims and Objectives:
The primary objective of this study is to compare gravity-driven versus wall suction-driven large volume therapeutic thoracentesis on the development of chest discomfort during the procedure.
Expected Outcomes:
We anticipate that gravity driven therapeutic thoracentesis will result in improved clinical outcomes compared to wall suction driven thoracentesis, defined by less chest discomfort throughout the procedure as measured at 5 minutes post-procedure (primary endpoint).
Primary endpoint:
The Global Pain Score will be determined at 5 minutes post-procedure using a VAS 0-100 and represents the pain experienced by the patient during the entire procedure from the beginning to the 5-minute post-procedure assessment ("On average, how much discomfort have you felt during the procedure?"). The primary endpoint is defined as the overall procedural chest pain scored 5 minutes following the procedure.
This study is a randomized controlled trial designed to compare the changes of chest pain scores between gravity-driven therapeutic thoracentesis and wall suction-driven thoracentesis. The estimated minimal clinically important difference of the change is 10.
Secondary endpoints:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Referral to pulmonary services for large-volume thoracentesis
Presence of a symptomatic moderate or large free-flowing (non-septated) pleural effusion on the basis of:
Age >/= 18
Exclusion criteria
Inability to provide informed consent
Study subject has any disease or condition that interferes with safe completion of the study including:
Pleural effusion is smaller than expected on bedside pre-procedure ultrasound
Referral is for diagnostic thoracentesis only
Presence of more than minimal septations and/or loculations( more than 3) on bedside pre-procedure ultrasound
Inability to sit for the procedure
Pregnancy
Primary purpose
Allocation
Interventional model
Masking
79 participants in 2 patient groups
Loading...
Central trial contact
Horianna Grosu, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal